Cerebellum’s Bed Bath & Beyond Inc BBBY Stock Holding History

Cerebellum’s Portfolio BBBY Stock Details BBBY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,498	Closed	-$121K	–	616
2020 Q2	$121K	Buy	+5,498	New	+$37.9K	0.09%	313
2018 Q1	–	Sell	-5,498	Closed	-$121K	–	554
2017 Q4	$121K	Buy	+5,498	New	+$119K	0.09%	313

Other funds holding BBBY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIM

Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Cerebellum's BBBY Position: Q3 2020 in Review

Cerebellum sold out of Bed Bath & Beyond Inc (BBBY) in Q3 2020, closing a stake of 5,498 shares — an estimated $121K sold.

Cerebellum first reported a position in BBBY in Q4 2017 and held it in 2 quarters. The position peaked at $121K in Q2 2020. 284 funds tracked by Wall St. Rank hold BBBY as of Q3 2020.

Cerebellum reported no remaining Bed Bath & Beyond Inc position as of Q3 2020 after selling out during the quarter.
Cerebellum sold 5,498 Bed Bath & Beyond Inc shares in Q3 2020, an estimated $121K.
Cerebellum first reported a position in Bed Bath & Beyond Inc in Q4 2017 and held it in 2 quarters.
Cerebellum's Bed Bath & Beyond Inc position peaked at $121K in Q2 2020.
284 funds tracked by Wall St. Rank held Bed Bath & Beyond Inc as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.